Nice, France

Ez-Zoubir Amri

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ez-Zoubir Amri: Innovator in Human Brown Adipocyte Research

Introduction

Ez-Zoubir Amri is a notable inventor based in Nice, France. He has made significant contributions to the field of adipocyte research, particularly in understanding human brown adipocytes and their role in energy homeostasis. With a total of 2 patents, his work has implications for treating obesity and related metabolic disorders.

Latest Patents

Amri's latest patents include the establishment of a human brown adipocyte line and a method for differentiation from an hMADS cell line. This invention focuses on a functional population of human brown adipocytes, characterized by higher expression levels of UCP1, CIDEA, CPT1B, and Bc12, while showing lower expression of Bax. Additionally, it outlines methods for differentiating hMADS cells into these brown adipocytes and converting white adipocytes into brown adipocytes. Another significant patent involves UCP1-inducing agents for treating disorders related to energy homeostasis, such as obesity and metabolic syndrome. This invention comprises compositions that upregulate UCP1 expression, providing a potential therapeutic avenue for these conditions.

Career Highlights

Throughout his career, Amri has worked with esteemed institutions, including the National Centre for Scientific Research (Centre National De La Recherche Scientifique) and the University of Nice Sophia Antipolis. His research has been pivotal in advancing the understanding of adipocyte biology and its implications for health.

Collaborations

Amri has collaborated with notable colleagues such as Gérard Paul Ailhaud and Christian Jean Lucien Dani. Their joint efforts have contributed to the advancements in the field of adipocyte research.

Conclusion

Ez-Zoubir Amri's innovative work in the field of human brown adipocytes has the potential to impact the treatment of obesity and metabolic disorders significantly. His patents reflect a commitment to advancing scientific knowledge and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…